Baird Expects FDA Rejection for Drisapersen and Eteplirsen (BMRN) (SRPT)
Go back to Baird Expects FDA Rejection for Drisapersen and Eteplirsen (BMRN) (SRPT)| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 66.70 -0.98 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.68 | 52 Week High | $108.96 | |||
| Open | $67.55 | 52 Week Low | $62.12 | |||
| Day High | $68.34 | P/E | N/A | |||
| Day Low | $66.52 | EPS | $-1.27 | |||
| Volume | 1,593,613 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.79 -0.43 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.22 | 52 Week High | $63.73 | |||
| Open | $19.39 | 52 Week Low | $8.00 | |||
| Day High | $19.73 | P/E | N/A | |||
| Day Low | $18.66 | EPS | $-5.69 | |||
| Volume | 1,674,598 | |||||
